Clinical Trials in New York

Showing 12361-12380 of 19,464 trials

A Study of ERY974 in Patient With Advanced Solid Tumors

NCT02748837

This is the open label, multicenter Phase 1 study which consists of a dose escalation to determine the maximum tolerated dose (MTD) and cohort expansion to obtain a preliminary evaluation of anti-tumor activity. ERY974 is intravenously injected to patients with Glypican 3 positive advanced solid tumors until unacceptable toxicity or disease progression.

Solid Tumors

Chugai Pharmaceutical29 participantsStarted Aug 2016

Washington D.C., District of Columbia, United States • Tampa, Florida, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

NCT02287922

The primary objective of this study is: \- To assess the efficacy and safety of dose regimens of ALX-0061 monotherapy administered subcutaneously (s.c.) to subjects with active rheumatoid arthritis (RA). The secondary objectives of this study are: * To assess the effects of ALX-0061 on quality of life, the pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of ALX-0061 and to explore potential dose regimens for ALX-0061 monotherapy, based on safety and efficacy, for further clinical development. * To obtain parallel descriptive information concerning the efficacy and safety of tocilizumab (TCZ) s.c. in the same clinical trial RA population.

Rheumatoid Arthritis

Ablynx, a Sanofi company251 participantsStarted Mar 2015

Birmingham, Alabama, United States • Hemet, California, United States • La Palma, California, United States +80 more locations

A Study of ERY974 in Patient With Advanced Solid Tumors

A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis

Find Trials by Condition in New York

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA

Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy

A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Intrathecal Hydromorphone for Pain Control After Cesarean Section

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps

Observational Study of Kibow Biotics in Chronic Kidney Failure Patients on Dialysis

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

IV Acetaminophen for Acute Post Operative Pain in C-Section Patients

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

A Double Balloon Endoscopic Platform for ESD

Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.

Does Use of Rapid Response EEG Impact Clinical Decision Making

An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)